Memorial Sloan-Kettering Cancer Center: Press Releases

Research Reveals What Drives Lung Cancer's Spread

Thu, 02 Jul 2009 13:00:00 GMT

NEW YORK, NY - A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.

Study Shows Drug Combination Improves Outcome for Advanced Non-Small Cell Lung Cancer

Sat, 30 May 2009 11:05:00 GMT

NEW YORK, NY - A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC).

Surgery Not Necessary for Most Late-Stage Colorectal Cancers

Sat, 30 May 2009 09:10:00 GMT

NEW YORK, NY - A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon.

Memorial Sloan-Kettering Investigator named Dream Team Leader by Stand Up To Cancer

Wed, 27 May 2009 10:05:00 GMT

NEW YORK, NY - Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a "Dream Team" leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women's cancers.

Genes Found to Play a Role in Breast Cancer's Spread to the Brain

Tue, 05 May 2009 13:00:00 GMT

NEW YORK, NY - New research led by investigators at Memorial Sloan-Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.

New Minimally Invasive Surgery Option for Patients with Stomach Cancer

Wed, 15 Apr 2009 11:00:00 GMT

NEW YORK, NY - A novel, minimally invasive surgical approach to treat stomach cancer has been shown to have advantages that may make it a preferable treatment for some patients.

Drug Shows Activity in Men with Advanced Prostate Cancer

Wed, 08 Apr 2009 15:00:00 GMT

NEW YORK, NY - A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.

Genetic Abnormality May Increase Risk of Blood Disorders

Tue, 17 Mar 2009 16:00:00 GMT

NEW YORK, NY - Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown for the first time that a tendency to develop some blood disorders may be inherited.

NIH Awards $15.9 Million to CCNY and Memorial Sloan-Kettering to Create Partnership to Address Cancer Disparities

Wed, 25 Feb 2009 06:00:00 GMT

NEW YORK, NY - The National Institutes of Health's National Cancer Institute has awarded The City College of New York and Memorial Sloan-Kettering Cancer Center a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach.

Nominations Sought for Paul Marks Prize

Tue, 03 Feb 2009 13:00:00 GMT

NEW YORK, NY - Nominations are currently being sought for the Paul Marks Prize for Cancer Research.

Childhood Cancer Survivors Not Following Recommended Screening Guidelines

Wed, 28 Jan 2009 09:00:00 GMT

NEW YORK, NY - The majority of young women at an increased risk of breast cancer due to chest radiation treatment for childhood cancer are not following breast cancer screening recommendations, according to a recently released, detailed assessment appearing in the January 28, 2009, issue of the Journal of the American Medical Association.

Why Cancer Drugs Are So Expensive and Why Medicare Can't Fix the Problem

Tue, 27 Jan 2009 18:00:00 GMT

NEW YORK, NY - A new health policy report which will be published in the New England Journal of Medicine suggests that the swift and dramatic rise in cancer-drug spending is due to laws that keep Medicare from managing the use or price of cancer drugs. These laws limit Medicare's actions in cancer far more than they are limited in other areas of healthcare.

Researchers Create Smaller, Brighter Probe, Tailored for Clinical Molecular Imaging and Tumor Targeting

Tue, 13 Jan 2009 06:00:00 GMT

NEW YORK, NY - Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.

Research Shows Cell's Inactive State is Critical for Effectiveness of Cancer Treatment

Tue, 13 Jan 2009 06:00:00 GMT

NEW YORK, NY - A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study's findings, researchers identified the genetic pathway used to maintain a cell's quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.

New Geoffrey Beene Gift to Memorial Sloan-Kettering Puts Total Support Over $100 Million

Thu, 09 Oct 2008 12:45:00 GMT

NEW YORK, NY - Memorial Sloan-Kettering Cancer Center has announced the gift of a membership interest in Geoffrey Beene, LLC, the company that controls the business and fashion empire created by legendary designer Geoffrey Beene.

New Study Examines Effectiveness of Colorectal Cancer Screening Tests and Suggests Screening May Be Stopped at Age 75

Mon, 06 Oct 2008 18:10:00 GMT

NEW YORK, NY - New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.

Innovative Relationship Advances Cancer Care in New Jersey

Thu, 02 Oct 2008 12:00:00 GMT

NEW YORK, NY - Memorial Sloan-Kettering Cancer Center and Summit Medical Group together announce a new collaborative relationship for the care of people with cancer.

American Tennis Star James Blake to Launch Cancer Research Fund in His Father's Name at Memorial Sloan-Kettering Cancer Center

Thu, 10 Jul 2008 12:00:00 GMT

NEW YORK, NY - American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan-Kettering Cancer Center.

Acupuncture Reduces Pain and Dysfunction in Head and Neck Cancer Patients after Neck Dissection

Sat, 31 May 2008 13:00:00 GMT

NEW YORK, NY - New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection.

Drug Fends Off Kidney Cancer Progression

Fri, 16 May 2008 17:00:00 GMT

NEW YORK, NY - New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.